Clinical trial

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)

NCT06283758

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-03-01

PhaseNA

Study timeline

Study start (actual)2024-03-01Date precision: day

Registry last updated2026-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Blood Pressureunresolved

Cardiovascular Diseasesunresolved

Interventions

focused power ultrasound mediate inferior perirenal adipose tissue modificationDEVICE

Sham-control groupDEVICE

Sponsors & collaborators

Suzhou Municipal Hospitallead sponsor

The Affiliated Jiangning Hospital of Nanjing Medical Universitycollaborator

The First Affiliated Hospital with Nanjing Medical Universitycollaborator

Affiliated Hospital of Nantong Universitycollaborator

Mapped research locations

NanjingJiangsu, China2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06283758 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.